A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

Description

A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.

Conditions

X-linked Hypophosphatemia

Study Overview

Study Details

Study overview

A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.

A Multicenter, Open-label, Phase 1/2, Dose-escalation and Subsequent Safety Extension Study of Subcutaneous KK8123 in Adult Patients With X-linked Hypophosphatemia

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

Condition
X-linked Hypophosphatemia
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California - San Francisco, San Francisco, California, United States, 94115

New Haven

Yale School of Medicine, New Haven, Connecticut, United States, 06510

Indianapolis

Indiana University School of Medicine University Hospital, Indianapolis, Indiana, United States, 46202

Nashville

Vanderbilt University Medical Center, Nashville, Tennessee, United States, 37232

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Part 1:
  • * Part 1:

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Kyowa Kirin, Inc.,

Kyowa Kirin, STUDY_CHAIR, Kyowa Kirin, Inc.

Study Record Dates

2028-05-10